Azenta Inc (NAS:AZTA)
$ 46.21 -0.9 (-1.91%) Market Cap: 2.11 Bil Enterprise Value: 1.74 Bil PE Ratio: 0 PB Ratio: 1.19 GF Score: 72/100

Azenta Inc at UBS Global Healthcare Conference Transcript

May 24, 2022 / 06:45PM GMT
Release Date Price: $69.17 (-2.26%)
Liza Garcia

So my name is Liza Garcia. I'm an analyst at the UBS Life Science Tools Diagnostics Group. And it is my pleasure to welcome Mr. Lindon Robertson, the CFO of Azenta, who will be giving a presentation.

Just very quickly before that, I do have to provide disclosures as an analyst at UBS with regards to my role and that of UBS. You can find the disclosures at ubs.com/disclosures.

And with that, please begin the presentation.

Lindon G. Robertson
Azenta, Inc. - Executive VP & CFO

That's great, Liza. Thank you very much, and thank you for everybody tuning in with us and appreciate the interest and attention. The UBS conference has been really good to us over the years. We appreciate the invitation again.

One more disclosure note. Of course, we have the safe harbor statement that we'll abide by, and we'll be making forward-looking statements. And we don't have the obligation to update those until into the future. So please take note that those are forward-looking statements as we talk.

The agenda today is I'm going to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot